Trademark: 88152710
Status Date
Monday, June 6, 2022
Filing Date
Friday, October 12, 2018
Published for Opposition
Tuesday, March 5, 2019
Abandoned Date
Monday, June 6, 2022
5 Pharmaceuticals for the treatment of neurodegenerative diseases and diseases of aging; blood plasma, plasma fractions in the nature of blood plasma as separated by sequential precipitation or other techniques, and human plasma products in the nature of blood plasma
Jun 6, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 6, 2022
Abandonment - No Use Statement Filed
Aug 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2021
Sou Extension 5 Granted
Aug 5, 2021
Sou Extension 5 Filed
Aug 11, 2021
Case Assigned To Intent To Use Paralegal
Aug 5, 2021
Sou Teas Extension Received
Feb 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 29, 2021
Sou Extension 4 Granted
Jan 29, 2021
Sou Extension 4 Filed
Jan 29, 2021
Sou Teas Extension Received
Aug 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 14, 2020
Sou Extension 3 Granted
Aug 14, 2020
Sou Extension 3 Filed
Aug 14, 2020
Sou Teas Extension Received
Apr 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 31, 2020
Sou Extension 2 Granted
Mar 31, 2020
Sou Extension 2 Filed
Mar 31, 2020
Sou Teas Extension Received
Aug 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 6, 2019
Sou Extension 1 Granted
Aug 6, 2019
Sou Extension 1 Filed
Aug 6, 2019
Sou Teas Extension Received
Apr 30, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2019
Published For Opposition
Feb 13, 2019
Notification Of Notice Of Publication E-Mailed
Jan 24, 2019
Approved For Pub - Principal Register
Jan 23, 2019
Assigned To Examiner
Oct 23, 2018
New Application Office Supplied Data Entered
Oct 16, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
